Literature DB >> 29887426

Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.

Parag Goyal1, Zaid I Almarzooq2, Jim Cheung3, Hooman Kamel4, Udhay Krishnan3, Dmitriy N Feldman3, Evelyn M Horn3, Luke K Kim3.   

Abstract

BACKGROUND: Atrial fibrillation (AF) and heart failure often occur concomitantly, representing a clinical phenotype at high-risk for poor outcomes. Differences in the characteristics, management, and in-hospital outcomes of AF among those with heart failure with preserved ejection fraction (HFpEF) and those with heart failure with reduced ejection fraction (HFrEF) are not well characterized. METHODS AND
RESULTS: Using the National Inpatient Sample, we identified hospitalizations in 2008-2012 for HFpEF and for HFrEF, with and without AF based on ICD-9-CM codes. We examined patient characteristics, procedural rates, and in-hospital outcomes. AF was common among both HFpEF and HFrEF, and increased in prevalence over the study period. A very low proportion of the cohort underwent either direct-current cardioversion or catheter-ablation. Compared to those without AF, those with AF experienced higher in-hospital mortality regardless of heart failure subtype. In multivariable regression analysis, AF was associated with in-hospital mortality in HFpEF (OR 1.10, CI [1.08-1.11]), but not in HFrEF (OR 0.93 [0.92-0.94], p-for-interaction < 0.001).
CONCLUSIONS: Our study revealed that the prevalence and adverse impact of AF on those with HFpEF is substantial, providing a rationale to rigorously investigate strategies, such as rhythm-control, to improve outcomes for this particularly vulnerable subpopulation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Epidemiology; Heart failure; Mortality

Mesh:

Year:  2018        PMID: 29887426      PMCID: PMC8819500          DOI: 10.1016/j.ijcard.2018.02.007

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  55 in total

1.  Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.

Authors:  Vojtech Melenovsky; Seok-Jae Hwang; Margaret M Redfield; Rosita Zakeri; Grace Lin; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2015-01-15       Impact factor: 8.790

2.  Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation.

Authors:  Jonathan P Piccini; Moritz F Sinner; Melissa A Greiner; Bradley G Hammill; João D Fontes; James P Daubert; Patrick T Ellinor; Adrian F Hernandez; Allan J Walkey; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis
Journal:  Circulation       Date:  2012-09-26       Impact factor: 29.690

3.  Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

Authors:  Clyde W Yancy; Margarita Lopatin; Lynne Warner Stevenson; Teresa De Marco; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2005-12-15       Impact factor: 24.094

4.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

5.  Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.

Authors:  Tomoko Machino-Ohtsuka; Yoshihiro Seo; Tomoko Ishizu; Akinori Sugano; Akiko Atsumi; Masayoshi Yamamoto; Ryo Kawamura; Takeshi Machino; Kenji Kuroki; Hiro Yamasaki; Miyako Igarashi; Yukio Sekiguchi; Kazutaka Aonuma
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

6.  Mortality Among Patients Hospitalized With Heart Failure and Diabetes Mellitus: Results From the National Inpatient Sample 2000 to 2010.

Authors:  Theingi Tiffany Win; Herbert T Davis; Warren K Laskey
Journal:  Circ Heart Fail       Date:  2016-05       Impact factor: 8.790

7.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

Authors:  Mohammed N Khan; Pierre Jaïs; Jennifer Cummings; Luigi Di Biase; Prashanthan Sanders; David O Martin; Josef Kautzner; Steven Hao; Sakis Themistoclakis; Raffaele Fanelli; Domenico Potenza; Raimondo Massaro; Oussama Wazni; Robert Schweikert; Walid Saliba; Paul Wang; Amin Al-Ahmad; Salwa Beheiry; Pietro Santarelli; Randall C Starling; Antonio Dello Russo; Gemma Pelargonio; Johannes Brachmann; Volker Schibgilla; Aldo Bonso; Michela Casella; Antonio Raviele; Michel Haïssaguerre; Andrea Natale
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

8.  Heart failure–associated hospitalizations in the United States.

Authors:  Saul Blecker; Margaret Paul; Glen Taksler; Gbenga Ogedegbe; Stuart Katz
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

Review 9.  Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.

Authors:  Dipak Kotecha; Carolyn S P Lam; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Adriaan A Voors; Michiel Rienstra
Journal:  J Am Coll Cardiol       Date:  2016-11-15       Impact factor: 24.094

10.  Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.

Authors:  Rajalakshmi Santhanakrishnan; Na Wang; Martin G Larson; Jared W Magnani; David D McManus; Steven A Lubitz; Patrick T Ellinor; Susan Cheng; Ramachandran S Vasan; Douglas S Lee; Thomas J Wang; Daniel Levy; Emelia J Benjamin; Jennifer E Ho
Journal:  Circulation       Date:  2016-01-08       Impact factor: 29.690

View more
  10 in total

Review 1.  Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes.

Authors:  Aakash Bavishi; Ravi B Patel
Journal:  Heart Fail Clin       Date:  2020-07-21       Impact factor: 3.179

Review 2.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

3.  Impact of atrial fibrillation on patients hospitalized for acute myocarditis: Insights from a nationally-representative United States cohort.

Authors:  Ahmed Subahi; Emmanuel Akintoye; Ahmed S Yassin; Hossam Abubakar; Oluwole Adegbala; Tushar Mishra; Mohamed Abdelrahman; Mohamed Shokr; Luis Afonso
Journal:  Clin Cardiol       Date:  2019-01-03       Impact factor: 2.882

4.  Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation.

Authors:  Yanhua Yang; Suxia Guo; Ziyao Huang; Chunhua Deng; Lihua Chen; Guoxiang Zhou; Zhengwei Jian; Ruping He; Zhichao Huang; Yongzhao Yao; Jiongbin Lu; Zhiwen Hua; Yuli Huang
Journal:  Cardiol Res Pract       Date:  2020-05-13       Impact factor: 1.866

5.  Predictors of Unfavorable Outcomes in Patients with Atrial Fibrillation and Concomitant Heart Failure with Different Ejection Fractions: RIF-CHF Register One-Year Follow-Up.

Authors:  Igor Zhirov; Natalia Safronova; Yulia Osmolovskaya; Alina Alshevskaya; Andrey Moskalev; Sergey Tereshchenko
Journal:  Cardiol Res Pract       Date:  2019-05-15       Impact factor: 1.866

6.  Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients.

Authors:  Manuel Rattka; Alexander Pott; Anna Kühberger; Karolina Weinmann; Dominik Scharnbeck; Tilman Stephan; Michael Baumhardt; Carlo Bothner; Mario Iturbe Orbe; Wolfgang Rottbauer; Tillman Dahme
Journal:  Europace       Date:  2020-09-01       Impact factor: 5.214

7.  Temporal Trends in Outcomes of ST-Elevation Myocardial Infarction Patients With Heart Failure and Diabetes.

Authors:  Bassem Ali; Soha Dargham; Jassim Al Suwaidi; Hani Jneid; Charbel Abi Khalil
Journal:  Front Physiol       Date:  2022-02-03       Impact factor: 4.566

8.  Performance of Electronic Health Record Diagnosis Codes for Ambulatory Heart Failure Encounters.

Authors:  Parag Goyal; Budhaditya Bose; Ruth Masterson Creber; Udhay Krishnan; Mei Yang; Joanne Brady; Jyotishman Pathak
Journal:  J Card Fail       Date:  2020-08-02       Impact factor: 5.712

Review 9.  Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction.

Authors:  Elisa Dal Canto; Sharon Remmelzwaal; Adriana Johanne van Ballegooijen; M Louis Handoko; Stephane Heymans; Vanessa van Empel; Walter J Paulus; Giel Nijpels; Petra Elders; Joline Wj Beulens
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

Review 10.  Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop.

Authors:  Sana M Al-Khatib; Emelia J Benjamin; Christine M Albert; Alvaro Alonso; Cynthia Chauhan; Peng-Sheng Chen; Anne B Curtis; Patrice Desvigne-Nickens; Jennifer E Ho; Carolyn S P Lam; Mark S Link; Kristen K Patton; Margaret M Redfield; Michiel Rienstra; Yves Rosenberg; Renate Schnabel; John A Spertus; Lynne Warner Stevenson; Mellanie True Hills; Adriaan A Voors; Lawton S Cooper; Alan S Go
Journal:  Circulation       Date:  2020-06-08       Impact factor: 29.690

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.